FDA appoints permanent leaders for drug and vaccine divisions after two years of turnover
The FDA has filled four senior roles, including naming Mikhail and Davis as permanent leaders of CBER and CDER respectively, bringing stability to the agency after nearly two years of leadership turnover under the Trump administration.